Asthma Conf 09: : Asthma Treatment and Safety

1. Multiple oral corticosteroid bursts over years of time can produce a dose-dependent reduction in bone mineral accretion and (increased risk for osteopenia) in children with asthma. Inhaled corticosteroid use might do the same in boys progressing through puberty, but this risk is likely to be outweighed by the ability to reduce the amount of oral corticosteroids used in these children.

True

False

Multiple oral corticosteroid bursts over years can lead to a decrease in bone mineral accretion and an increased risk for osteopenia in children with asthma. Inhaled corticosteroid use may also have a similar effect in boys going through puberty, but the benefits of reducing the need for oral corticosteroids outweigh this risk. Therefore, the statement is true.

Explanation

Multiple oral corticosteroid bursts over years can lead to a decrease in bone mineral accretion and an increased risk for osteopenia in children with asthma. Inhaled corticosteroid use may also have a similar effect in boys going through puberty, but the benefits of reducing the need for oral corticosteroids outweigh this risk. Therefore, the statement is true.

2. The risks of (Glucocorticosteroid, GCS) corticosteroids use decrease when the medications are inhaled, at a low dose with a newer drug with negative growth studies.

True

False

The explanation for the given correct answer is that inhaled glucocorticosteroid (GCS) corticosteroids have a lower risk of side effects compared to other forms of corticosteroids. This is because when the medication is inhaled, it is delivered directly to the lungs and has a localized effect, reducing the systemic absorption and potential for systemic side effects. Additionally, newer drugs with negative growth studies indicate that they have been studied extensively and have shown no negative effects on growth, further decreasing the risks associated with their use. Therefore, it is true that the risks of GCS corticosteroids decrease when the medications are inhaled, at a low dose with a newer drug with negative growth studies.

Explanation

The explanation for the given correct answer is that inhaled glucocorticosteroid (GCS) corticosteroids have a lower risk of side effects compared to other forms of corticosteroids. This is because when the medication is inhaled, it is delivered directly to the lungs and has a localized effect, reducing the systemic absorption and potential for systemic side effects. Additionally, newer drugs with negative growth studies indicate that they have been studied extensively and have shown no negative effects on growth, further decreasing the risks associated with their use. Therefore, it is true that the risks of GCS corticosteroids decrease when the medications are inhaled, at a low dose with a newer drug with negative growth studies.

3. Studies show cataracts and glaucoma risks only go up when at high doses of inhaled steroids. At low doses there is not much risk shown.

True

False

The given statement suggests that studies have shown an increase in the risks of cataracts and glaucoma only when high doses of inhaled steroids are used. At low doses, there is not much risk shown. Therefore, the correct answer is true, indicating that the statement is supported by evidence from studies.

Explanation

The given statement suggests that studies have shown an increase in the risks of cataracts and glaucoma only when high doses of inhaled steroids are used. At low doses, there is not much risk shown. Therefore, the correct answer is true, indicating that the statement is supported by evidence from studies.

4. What is the #1 risk to patients with asthma?

Treated with oral corticosteroid

Treated, stepped-down doses of inhaled corticosteroids

Treated with greater than recommended doses of inhaled corticosteroid

Untreated poorly controlled disease

Treated with recommended doses of inhaled corticosteroid

Untreated poorly controlled disease is the #1 risk to patients with asthma because it can lead to severe symptoms and exacerbations. When asthma is not properly managed, inflammation and constriction of the airways can occur, making it difficult for the patient to breathe. This can result in frequent hospitalizations, decreased quality of life, and even life-threatening asthma attacks. Therefore, it is crucial for patients with asthma to receive appropriate treatment and regularly monitor their symptoms to ensure their disease is well-controlled.

Explanation

Untreated poorly controlled disease is the #1 risk to patients with asthma because it can lead to severe symptoms and exacerbations. When asthma is not properly managed, inflammation and constriction of the airways can occur, making it difficult for the patient to breathe. This can result in frequent hospitalizations, decreased quality of life, and even life-threatening asthma attacks. Therefore, it is crucial for patients with asthma to receive appropriate treatment and regularly monitor their symptoms to ensure their disease is well-controlled.

5. According to the GAPP survey, who initiates discussion about asthma medication side effects, adult patients or physicians?

Adult patients are most likely to initiate the conversation

Physicians are most likely to initiate the conversation

Adult patients and physicians both thought they initiated the conversation themselves

This conversation frequently didn’t occur

The correct answer is that adult patients and physicians both thought they initiated the conversation themselves. This means that both parties believed they were the ones starting the discussion about asthma medication side effects. It suggests that there is a shared responsibility and interest in addressing this topic, with both patients and physicians actively engaging in conversations about potential side effects.

Explanation

The correct answer is that adult patients and physicians both thought they initiated the conversation themselves. This means that both parties believed they were the ones starting the discussion about asthma medication side effects. It suggests that there is a shared responsibility and interest in addressing this topic, with both patients and physicians actively engaging in conversations about potential side effects.

Asthma Conf 09: : Asthma Treatment And Safety